<SEC-DOCUMENT>0001193125-25-022242.txt : 20250207
<SEC-HEADER>0001193125-25-022242.hdr.sgml : 20250207
<ACCEPTANCE-DATETIME>20250207063520
ACCESSION NUMBER:		0001193125-25-022242
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250206
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250207
DATE AS OF CHANGE:		20250207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardant Health, Inc.
		CENTRAL INDEX KEY:			0001576280
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				454139254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38683
		FILM NUMBER:		25599212

	BUSINESS ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		855-698-8887

	MAIL ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d931211d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gh="http://guardanthealth.com/20250206" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-286">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-02-06_to_2025-02-06">0001576280</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="gh-20250206.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-02-06_to_2025-02-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001576280</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-06</xbrli:startDate> <xbrli:endDate>2025-02-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-297">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt:datemonthdayyearen" id="ixv-298">February&#160;6, 2025</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-299">GUARDANT HEALTH, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:stateprovnameen" id="ixv-300">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-301">001-38683</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-302">45-4139254</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-303">3100 Hanover Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-304">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:stateprovnameen" id="ixv-305">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-306">94304</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-307">855</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-308">698-8887</ix:nonNumeric></span></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, include area code)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:boolballotbox" id="ixv-309">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:boolballotbox" id="ixv-310">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:boolballotbox" id="ixv-311">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:boolballotbox" id="ixv-312">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-313">Common Stock, $0.00001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-314">GH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:exchnameen" id="ixv-315">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-02-06_to_2025-02-06" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;6, 2025, Guardant Health, Inc. (the &#8220;Company&#8221;) entered into privately negotiated exchange agreements (the &#8220;Exchange Agreements&#8221;) with certain holders of its outstanding 0% Convertible Senior Notes due 2027 (the &#8220;2027 Notes&#8221;), pursuant to which the Company will issue $600&#160;million aggregate principal amount of 1.25% Convertible Senior Notes due 2031 (the &#8220;New Notes&#8221;) in exchange for the retirement of approximately $659.3&#160;million principal amount of 2027 Notes (the &#8220;Transactions&#8221;). Following the closing of the Transactions, which is expected to occur on or about February&#160;14, 2025 (the &#8220;Closing Date&#8221;), subject to customary closing conditions, approximately $490.7&#160;million in aggregate principal amount of 2027 Notes will remain outstanding with terms unchanged. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Transactions, the Company intends to repurchase approximately $45&#160;million of shares of its common stock (the &#8220;common stock&#8221;), from certain participants in the Transactions through a financial intermediary at the last reported sale price of the common stock on February 6, 2025, and the Company has been advised that the exchange agent for the Exchange Transactions intends to purchase approximately $35&#160;million of shares of the Company&#8217;s common stock from certain participants in the Transactions through a financial intermediary at the last reported sale price of the common stock on February 6, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New Notes will be issued pursuant to, and governed by, an indenture (the &#8220;New Notes Indenture&#8221;), dated as of the Closing Date, between the Company and U.S. Bank Trust Company, National Association, as trustee (the &#8220;Trustee&#8221;).&#160;When issued pursuant to the New Notes Indenture, the New Notes will be senior unsecured obligations of the Company and will bear interest at a rate of 1.25% per annum, payable semi-annually in arrears on each February&#160;15 and August&#160;15, commencing on August&#160;15, 2025. Special interest may accrue on the New Notes in certain circumstances at a rate per annum not to exceed 0.50% (subject to certain exceptions). The New Notes will mature on February&#160;15, 2031, unless earlier repurchased, redeemed or converted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before November&#160;15, 2030, noteholders will have the right to convert their New Notes only upon the occurrence of certain events. From and after November&#160;15, 2030, noteholders may convert their New Notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. The Company will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company&#8217;s election. The initial conversion rate will be 16.0716 shares of common stock per $1,000 principal amount of Notes, which represents an initial conversion price of approximately $62.22 per share of common stock, which reflects a conversion premium of approximately 35% to the last reported sale price of the Company&#8217;s common stock on February&#160;6, 2025. The conversion rate and conversion price will be subject to customary adjustments upon the occurrence of certain events. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may not redeem the New Notes at its option at any time before February&#160;21, 2028. The New Notes will be redeemable, in whole or in part (subject to the &#8220;Partial Redemption Limitation&#8221; (as defined in the New Notes Indenture)), at the Company&#8217;s option at any time, and from time to time, on or after February&#160;21, 2028 and on or before the 25<sup style="font-size:75%; vertical-align:top">th</sup> scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the New Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date, but only if the last reported sale price per share of the Company&#8217;s common stock exceeds 130% of the conversion price on (i)&#160;each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii)&#160;the trading day immediately before the date the Company sends such notice. In addition, calling any New Note for redemption will constitute a Make-Whole Fundamental Change with respect to that New Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New Notes Indenture will provide that, if certain corporate events that constitute a &#8220;Fundamental Change&#8221; (as defined in the New Notes Indenture) occur, then, subject to a limited exception for certain cash mergers, noteholders may require the Company to repurchase their New Notes at a cash repurchase price equal to the principal amount of the New Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The definition of Fundamental Change includes certain business combination transactions involving the Company and <span style="white-space:nowrap">certain&#160;de-listing&#160;events</span> with respect to the Company&#8217;s common stock. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New Notes have customary provisions relating to the occurrence of &#8220;Events of Default&#8221; (as defined in the New Notes Indenture), which include the following: (i)&#160;certain payment defaults on the New Notes (which, in the case of a default in the payment of interest on the Notes, will be subject to a <span style="white-space:nowrap">30-day</span> cure period); (ii) the Company&#8217;s failure to send certain notices under the New Notes Indenture within specified periods of time; (iii)&#160;the Company&#8217;s failure to comply with certain covenants in the Indenture relating to the Company&#8217;s ability to consolidate with or merge with or into, or sell, lease or otherwise transfer, in one transaction or a series of transactions, all or substantially all of the assets of the Company and its subsidiaries, taken as a whole, to another person; (iv)&#160;a default by the Company in its other obligations or agreements under the New Notes Indenture or the New Notes if such default is not cured or waived within 60 days after notice is given in accordance with the New Notes Indenture; (v)&#160;certain defaults by the Company or any of its significant subsidiaries with respect to indebtedness for borrowed money of at least $100,000,000; and (vi)&#160;certain events of bankruptcy, insolvency and reorganization involving the Company or any of the Company&#8217;s significant subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default involving bankruptcy, insolvency or reorganization events with respect to the Company (and not solely with respect to a significant subsidiary of the Company) occurs, then the principal amount of, and any accrued and unpaid interest on, all of the New Notes then outstanding will immediately become due and payable without any further action or notice by any person. If any other Event of Default occurs and is continuing, then, the Trustee, by notice to the Company, or noteholders of at least 25% of the aggregate principal amount of New Notes then outstanding, by notice to the Company and the Trustee, may declare the principal amount of, and any accrued and unpaid interest on, all of the New Notes then outstanding to become due and payable immediately. However, notwithstanding the foregoing, the Company may elect, at its option, that the sole remedy for an Event of Default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture consists exclusively of the right of the noteholders to receive special interest on the New Notes for up to 180 days at a specified rate per annum not exceeding 0.50% on the principal amount of the New Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New Notes will be issued pursuant to the exemption from registration provided by Section&#160;4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The Company is relying on this exemption from registration based in part on representations made by the investors in the New Notes in the Exchange Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Form of Exchange Agreement is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. The foregoing description of the Form of Exchange Agreement is qualified in its entirety by reference to such exhibit. A copy of the press release announcing the Transactions is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> does not constitute an offer to sell, nor is it a solicitation of an offer to buy, the New Notes or the Company&#8217;s common stock, nor shall there be any sale of the New Notes or the Company&#8217;s common stock in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or any jurisdiction. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Information set forth under Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. Any shares of the Company&#8217;s common stock that may be issued upon conversion of the New Notes will be issued in reliance upon Section&#160;3(a)(9) of the Securities Act as involving an exchange by the Company exclusively with its security holders. Initially, a maximum of 13,017,960 shares of the Company&#8217;s common stock may be issued upon conversion of the Notes based on the initial maximum conversion rate of 21.6966 shares of common stock per $1,000 principal amount of Notes, which is subject to customary anti-dilution adjustment provisions. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit<br/>No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d931211dex101.htm">Form of Exchange Agreement</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d931211dex991.htm">Press release of Guardant Health, Inc., dated February&#160;7, 2025</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">GUARDANT HEALTH, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: February&#160;7, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Bell</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Michael Bell</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Accounting Officer and Principal Financial Officer)</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d931211dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;6, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3100 Hanover Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, California 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Chief Financial Officer </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exchange and/or Subscription for Guardant Health, Inc. Convertible Senior Notes due 2031
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant
Health, Inc., a Delaware corporation, (the &#147;<B>Company</B>&#148;), is offering a new series of its Convertible Senior Notes due 2031 (the &#147;<B>New Notes</B>&#148;). The New Notes will be convertible into cash, shares (&#147;<B>Underlying
Shares</B>&#148;) of common stock of the Company, par value $0.00001 per share (&#147;<B>Stock</B>&#148;), or a combination of cash and Underlying Shares, at the Company&#146;s election, in accordance with the terms of the Indenture (as defined
below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned (the &#147;<B>Investor</B>&#148;), for itself and, on behalf of the accounts (if any) listed on (x)<U>&nbsp;Exhibit A</U> hereto,
in the case of the Exchange (as defined below), for whom the Investor has been duly authorized to enter into the Exchange (each, including the Investor if it is listed on <U>Exhibit A</U>, an &#147;<B>Exchanging Holder</B>&#148;) and
(y)<U>&nbsp;Exhibit B</U> hereto, in the case of the Subscription (as defined below), for whom the Investor has been duly authorized to enter into the Subscription (each, including the Investor if it is listed on <U>Exhibit B</U>, a
&#147;<B>Subscriber</B>&#148;), may: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) exchange 0% Convertible Senior Notes due 2027 (CUSIP 40131MAB5 and ISIN: US40131MAB54) of the
Company (the &#147;<B>Old Notes</B>&#148;) for an amount of New Notes determined as set forth herein (the &#147;<B>Exchange</B>&#148;); and/or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) subscribe for and purchase from the Company New Notes for cash (the &#147;<B>Subscription</B>&#148; and, the Exchange and/or the
Subscription, as applicable, the &#147;<B>Notes Transactions</B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, pursuant and subject to the terms and conditions set forth in this
agreement (the &#147;<B>Exchange/Subscription </B><B>Agreement</B>&#148; or this &#147;<B>Agreement</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exchanging Holders and the
Subscribers (including the Investor, as applicable) are referred to collectively as the &#147;<B>Purchasers,</B>&#148; and each Purchaser (other than the Investor) is referred to herein as an &#147;<B>Account</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Investor hereby confirms that this Agreement relates to participation by the Purchasers, taken together, in the: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange only&#8194;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Subscription only&#8194;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Exchange and Subscription&#8194;&#9744;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Investor and each Account understands that the Notes Transactions are being made without registration under the Securities Act of 1933, as amended (the
&#147;<B>Securities Act</B>&#148;), or any securities laws of any state of the United States or of any other jurisdiction, and that the Notes Transactions are only being made to investors who are institutional &#147;accredited investors&#148; within
the meaning of Rule 501 of Regulation D under the Securities Act that are also &#147;qualified institutional buyers&#148; (within the meaning of Rule 144A under the Securities Act) in reliance upon an exemption from registration under
Section&nbsp;4(a)(2) of the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities Act. The Notes Transactions are described in, and will be made pursuant to, the Indenture relating to the New Notes (the<B> </B>&#147;<B>Indenture</B>&#148;) to be entered into as of
the Closing Date (as defined below) between the Company and U.S. Bank Trust Company, National Association, as Trustee (the &#147;<B>New Notes</B> <B>Trustee</B>&#148;), substantially in the form of the draft Indenture provided to Investor, as
supplemented by the Pricing Term Sheet, dated as of the date hereof (the &#147;<B>Pricing Term Sheet</B>&#148; and, together with the Indenture, the<B> &#147;Transaction Documents</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the issuance of the New Notes, the Company expects to repurchase shares of its Stock from certain institutional investors (the
&#147;<B>Share Repurchase</B>&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>The Exchange</U>. If the Investor and/or any other Exchanging Holders are participating in the Exchange,
subject to the terms and conditions of this Exchange/Subscription Agreement, the Investor and the other Exchanging Holders hereby deliver, assign and transfer to the Company all right, title and interest in the aggregate principal amount of Old
Notes set forth in column 2 of <U>Exhibit A</U> hereto (such principal amount of Old Notes, the &#147;<B>Exchanged Old Notes</B>&#148;) in exchange for New Notes having an aggregate principal amount, for each Exchanging Holder, as set forth in
column 3 of <U>Exhibit A</U> (such aggregate principal amount of New Notes, the &#147;<B>Exchanged New Notes</B>&#148;), and the Company agrees to issue such Exchanged New Notes to the Exchanging Holders in exchange for such Exchanged Old Notes. For
the avoidance of doubt, Exchanged New Notes will be issued in denominations of $1,000 principal amount and integral multiples thereof, and the Company will not make any separate cash payment in respect of rounded amounts or interest, if any, accrued
and unpaid to the Closing Date (as defined below) for the Exchanged Old Notes. Instead, such amounts will be deemed to be paid in full rather than cancelled, extinguished or forfeited upon exchange of the Exchanged Old Notes for the Exchanged New
Notes. Subject to the terms and conditions of this Exchange/Subscription Agreement, the Investor, on behalf of itself and each Exchanging Holder, hereby (a)&nbsp;waives any and all other rights with respect to such Exchanged Old Notes, and
(b)&nbsp;releases and discharges the Company from any and all claims the Investor and each Exchanging Holder may now have, or may have in the future, arising out of, or related to, such Exchanged Old Notes. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>The Subscription</U>. If the Investor and/or any other Subscriber is participating in the Subscription,
subject to the terms and conditions of this Exchange/Subscription Agreement, the Investor hereby agrees to purchase from the Company, and the Company hereby agrees to issue and sell to the Investor and/or any such Account, New Notes (the
&#147;<B>Purchased New Notes</B>&#148;) having an aggregate principal amount as set forth in column 2 of <U>Exhibit B</U> hereto, for an aggregate purchase price in cash in respect of such Purchased New Notes as set forth in column 3 of <U>Exhibit
B</U> (such aggregate cash purchase price, the &#147;<B>Cash Purchase Price</B>&#148;). For the avoidance of doubt, such Cash Purchase Price shall not be adjusted for accrued interest if the Closing (as defined below) occurs after February&nbsp;14,
2025. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>The Closing</U>. The closing of the Notes Transactions (the &#147;<B>Closing</B>&#148;) shall take place
electronically at 10:00 AM, New York City time, on February&nbsp;14, 2025, or at such other time and place as the Company may designate by notice to the Investor (the &#147;<B>Closing Date</B>&#148;); provided that the Closing Date cannot be later
than February&nbsp;28, 2025 without the prior written consent of the Investor. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Closing Mechanics</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Depository Trust Company (&#147;<B>DTC</B>&#148;) will act as securities depositary for the New Notes.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At or prior to the times set forth in the Exchange/Subscription Procedures set forth in <U>Exhibit C</U> hereto
(the &#147;<B>Exchange/Subscription Procedures</B>&#148;), the Investor, on behalf of itself and/or any other Account, shall: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if participating in the Exchange only, deliver and/or cause the Exchanging Holders to deliver the Exchanged Old
Notes, by book entry transfer through the facilities of DTC, to U.S. Bank Trust Company, National Association, in its capacity as trustee of the Old Notes (in such capacity, the &#147;<B>Old Notes Trustee</B>&#148;), for the account/benefit of the
Company for cancellation as instructed in the Exchange/Subscription Procedures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if participating in the Subscription only, transfer the Cash Purchase Price by wire in immediately available
funds to the account of the Company designated in the Exchange/Subscription Procedures; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if participating in both the Exchange and the Subscription: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deliver and/or cause the Exchanging Holders to deliver the Exchanged Old Notes, by book entry transfer through
the facilities of DTC, to the Old Notes Trustee, for the account/benefit of the Company for cancellation as instructed in the Exchange/Subscription Procedures; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfer the Cash Purchase Price by wire in immediately available funds to the account of the Company
designated in the Exchange/Subscription Procedures. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the Closing Date, subject to satisfaction of the conditions precedent specified in
<U>Section</U><U></U><U>&nbsp;7</U> hereof, and (1)&nbsp;the prior receipt by the Old Notes Trustee from each Exchanging Holder of the Exchanged Old Notes, if the Investor and/or any other Exchanging Holder is participating in the Exchange only
pursuant to <U>clause (b)</U><U>(i)</U> above, (2)&nbsp;the prior receipt by the Company of the Cash Purchase Price from the Investor on behalf of each Subscriber, if such Subscriber is participating in the Subscription only pursuant to <U>clause
(b)</U><U>(ii)</U> above, and (3)&nbsp;the prior receipt by the Old Notes Trustee from each Purchaser of the Exchanged Old Notes to be submitted for exchange by such Purchaser and the prior receipt by the Company of the Cash Purchase Price from such
Purchaser if such Purchaser is participating in both the Exchange and the Subscription pursuant to <U>clause (b)(i</U><U>i</U><U>i)</U> above: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company shall execute and deliver the Indenture, dated as of the Closing Date, between the Company and the
New Notes Trustee; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company shall execute, cause the New Notes Trustee to authenticate and cause to be delivered to the DTC
account(s) specified by the Investor or the relevant Account in <U>Exhibit D</U> hereto, the Exchanged New Notes (if the Investor and/or any Exchanging Holder is participating in the Exchange) and/or the Purchased New Notes (if the Investor and/or
any Subscriber is participating in the Subscription), as the case may be. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All questions as to the form of all documents
and the validity and acceptance of the Old Notes and the New Notes will be determined by the Company, in its sole discretion, which determination shall be final and binding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Investor (and
each Account, as applicable) that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Organization</I>. The Company is duly organized and is validly existing under the laws of the State of
Delaware. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Due Authorization</I>. This Exchange/Subscription Agreement has been duly authorized, executed and delivered
by the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>New Notes. </I>The New Notes have been duly authorized by the Company and, when duly executed by the Company
in accordance with the terms of the Indenture, assuming due authentication of the New Notes by the New Notes Trustee, upon delivery to the Investors in accordance with the terms of the Exchange and/or Subscription, as applicable, will be validly
issued and delivered and will constitute valid and binding obligations of the Company entitled to the benefits of the Indenture, enforceable against the Company in accordance with their terms, except as such enforceability may be limited by
bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors&#146; rights generally and by general equitable principles (regardless of whether such enforceability is considered in a
proceeding in equity or at law) (collectively, the &#147;<B>Enforceability Exceptions</B>&#148;). The maximum number of Underlying Shares initially issuable upon conversion of the New Notes (assuming settlement in shares of Stock to the maximum
extent permitted by the Indenture and taking into account the maximum make-whole adjustment under the Indenture) have been duly and validly authorized and reserved for by the Company and, when issued upon conversion of the New Notes in accordance
with the terms of the New Notes and the Indenture, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and the issuance of any Underlying Shares will not be subject to any preemptive, participation, rights
of first refusal or similar rights. At or prior to the Closing, a notice for the listing of additional shares covering the Underlying Shares shall have been submitted to the Nasdaq Global Select Market. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Indenture.</I> The Company has all requisite corporate power and authority to perform its obligations under
the Indenture. The Indenture has been duly authorized by the Company, and will have been duly executed and delivered by the Company on or prior to the Closing. Assuming due authorization, execution and delivery by the New Notes Trustee thereto, the
Indenture, upon execution and delivery thereof by the Company, will constitute the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Exemption from Registration. </I>Assuming the accuracy of the representations and warranties of the Investor
and each other investor executing an Exchange/Subscription Agreement, (1)&nbsp;each of the issuance of the Exchanged New Notes in connection with the Exchange and/or the issuance of the Purchased New Notes in connection with the Subscription, as the
case may be, pursuant to this Exchange/Subscription Agreement is exempt from the registration requirements of the Securities Act; and (2)&nbsp;the Indenture is not required to be qualified under the Trust Indenture Act of 1939, as amended.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>New Class. </I>The New Notes, when issued, will not be of the same class as securities listed on a national
securities exchange registered under Section&nbsp;6 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or quoted in a U.S. automated inter-dealer quotation system, within the meaning of Rule 144A(d)(3)(i) under the
Securities Act. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>No Conflicts</I>. The issuance of the New Notes pursuant to the Exchange/Subscription Agreements, the
execution, delivery and performance, as applicable, by the Company of its obligations under the New Notes, the Indenture and each Exchange/Subscription Agreement, and the consummation of the transactions contemplated hereby and thereby, will not
(i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company or its subsidiaries, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets
of the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational document of the Company or any of its subsidiaries
or (iii)&nbsp;result in any violation of any statute or any judgment, order, decree, rule or regulation of any court or arbitrator or federal, state, local or foreign governmental agency or regulatory authority having jurisdiction over the
properties or assets of the Company or any of its subsidiaries or any of their properties or assets, except, with respect to clauses (i)&nbsp;and (iii), conflicts, breaches, violations, impositions or defaults that would not reasonably be expected
to have a material adverse effect on the condition (financial or otherwise), results of operations, stockholders&#146; equity, properties, business or prospects of the Company and its subsidiaries taken as a whole or a material adverse effect on the
performance by the Company of its obligations under any Exchange/Subscription Agreement, the Indenture relating to the Old Notes, the Indenture or the New Notes or the consummation of any of the transactions contemplated hereby or thereby.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Share Repurchase</I>. The Share Repurchase has been duly authorized by the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Solvency</I>. On each of the date hereof and immediately after giving effect to the Exchange on the Closing
Date, (A)&nbsp;the present fair market value (or present fair saleable value) of the total assets of Company is not less than the total amount required to pay the probable total liabilities (including contingent liabilities) of the Company as they
mature and become absolute, (B)&nbsp;the capital of the Company is adequate to conduct its business and to enter into the Exchange, (C)&nbsp;the Company has the ability to pay its debts and obligations as such debts mature, and (D)&nbsp;the Company
is not &#147;insolvent&#148; (as such term is defined under Section&nbsp;101(32) of the U.S. Bankruptcy Code (Title 11 of the United States Code)). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">j.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Exchange</I>. The Company acknowledges that the terms of the Notes Transactions have been mutually
negotiated between the parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Representations and Warranties of the Investor</U>. The Investor hereby represents and warrants to and
covenants with the Company, on behalf of itself and each Account, as applicable, that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor is a corporation, limited partnership, limited liability company or other entity, as the case may
be, duly formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation, organization or formation, as applicable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Investor is participating in the Exchange, the Investor has all requisite corporate, limited
partnership, limited liability company or other applicable entity power and authority to deliver, assign and transfer the Exchanged Old Notes in exchange for the Exchanged New Notes pursuant to this Agreement and to enter into this
Exchange/Subscription Agreement and perform all obligations required to be performed by the Investor hereunder. This Agreement, when executed and delivered, has been duly authorized, executed and delivered by the Investor and constitutes the valid
and binding obligation of the Investor and each Exchanging Holder, enforceable in accordance with its terms, except that such enforcement may be subject to the Enforceability Exceptions. If the Investor is executing this Exchange/Subscription
Agreement on behalf of an Account, (i)&nbsp;the Investor has all requisite discretionary and contractual authority to enter into this Exchange/Subscription </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Agreement on behalf of, and, bind, each Account to the terms of this Agreement, (ii)<U>&nbsp;Exhibit A</U> hereto is a true, correct and complete list of (A)&nbsp;the name of each Exchanging
Holder and (B)&nbsp;the principal amount of each Exchanging Holder&#146;s Exchanged Old Notes and (iii)<U>&nbsp;Exhibit B</U> hereto is a true, correct and complete list of the name of each Subscriber and the aggregate principal amount of Purchased
New Notes each such Subscriber agrees to purchase hereunder. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Exchanging Holder participating in the Exchange is the current beneficial owner of the Exchanged Old
Notes. When the Exchanged Old Notes are exchanged, the Company will acquire good, marketable and unencumbered title thereto, free and clear of all liens, restrictions, charges, encumbrances, adverse claims, rights or proxies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Participation in the Notes Transactions will not contravene (1)&nbsp;any law, rule, regulation or governmental
or judicial decrees, injunctions or orders binding on the Investor or any Account or any investment guideline or restriction applicable to the Investor (or, if applicable, any Account), (2) the charter or bylaws (or equivalent organizational
documents) of the Investor (or, if applicable, any Account) or (3)&nbsp;any agreement or instrument to which the Investor or any Account is a party or by which the Investor or any Account or any of their respective assets are bound.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor (or applicable Account) is a resident of the jurisdiction set forth in <U>Exhibit D</U> and,
unless otherwise set out in <U>Exhibit A</U> or <U>Exhibit B</U> hereto, as applicable, is not acquiring the Exchanged New Notes or the Purchased New Notes as a nominee or agent or otherwise for any other person. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account will comply with all applicable laws and regulations in effect in any
jurisdiction in which the Investor or such Account purchases or acquires pursuant to the Exchange or Subscription, as the case may be, or sells New Notes and will obtain any consent, approval or permission required for such purchases, acquisitions
or sales under the laws and regulations of any jurisdiction to which the Investor or such Account is subject or in which the Investor or such Account makes such purchases, acquisitions or sales, and the Company shall not have any responsibility
therefor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account has received a copy of the Transaction Documents. The Investor acknowledges that:
(1)&nbsp;no person has been authorized to give any information or to make any representation concerning the Notes Transactions or the Company or any of its subsidiaries, other than as contained in this Agreement or the Transaction Documents or in
the information given by the Company&#146;s duly authorized officers and employees in connection with the Investor&#146;s examination of the Company and its subsidiaries and the terms of the Notes Transactions; and (2)&nbsp;the Company and its
subsidiaries do not take any responsibility for, and cannot provide any assurance as to the reliability of, any other information that may have been provided to the Investor. The Investor hereby acknowledges that J. Wood Capital Advisors LLC (the
&#147;<B>Placement Agent</B>&#148;) does not take any responsibility for, and can provide no assurance as to the reliability of, the information set forth in the Transaction Documents or any such other information provided or deemed provided to the
Investor by the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account understands and accepts that acquiring the New Notes in the Notes Transactions
involves risks. The Investor and each Account has such knowledge, skill and experience in business, financial and investment matters that the Investor and each Account is capable of evaluating the merits and risks of the Notes Transactions and an
investment in the New Notes. With the assistance of its own professional advisors (to the extent the Investor and each Account has deemed appropriate), the Investor and each Account has made its own legal, tax, accounting and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
financial evaluation of the merits and risks of an investment in the New Notes and the consequences of the Notes Transactions and this Agreement. The Investor and each Account has considered the
suitability of the New Notes as an investment in light of its own circumstances and financial condition, and the Investor is and each Account is able to bear the risks associated with an investment in the New Notes. The Investor and each Account
understands that it should consult with its own tax advisors in order to determine the U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of the Exchange (if participating in the Exchange) as well as the
ownership, disposition or conversion of the New Notes or Underlying Shares, in light of the Investor&#146;s and each Account&#146;s particular circumstances. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor confirms that neither it nor any Account is relying on any communication (written or oral) of the
Company or the Placement Agent or any of their respective agents or affiliates as investment advice or as a recommendation to participate in the Notes Transactions and receive the New Notes pursuant to the terms hereof. The Investor confirms that it
has read the Indenture relating to the New Notes and has not relied on any statement (written or oral) of the Company, the Placement Agent or any of their respective affiliates as to the terms of the New Notes. It is understood that information
provided in the Transaction Documents, or by the Company or the Placement Agent or any of their respective agents or affiliates, shall not be considered investment advice or a recommendation with respect to the Notes Transactions, and that none of
the Company, the Placement Agent or any of their respective agents or affiliates is acting or has acted as an advisor to the Investor or any Account in deciding whether to participate in the Notes Transactions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">j.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor confirms, for itself and for each Account, that neither the Company nor the Placement Agent have
(1)&nbsp;given any guarantee or representation as to the potential success, return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the New Notes; or (2)&nbsp;made any representation to the
Investor regarding the legality of an investment in the New Notes under applicable investment guidelines, laws or regulations. In deciding to participate in the Notes Transactions, neither the Investor nor any Account is relying on the advice or
recommendations of the Company or the Placement Agent, and the Investor and each Account has made its own independent decision that the investment in the New Notes is suitable and appropriate for the Investor or such Account. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">k.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account is a sophisticated participant in the transactions contemplated hereby and has
such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the New Notes, is experienced in investing in capital markets and is able to bear the economic risk of an
investment in the New Notes. The Investor and each Account is familiar with the business and financial condition and operations of the Company and its subsidiaries and has conducted its own investigation of the Company and its subsidiaries and the
New Notes and has consulted with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby. The Investor and each Account has had access to
the Company&#146;s filings with the Securities and Exchange Commission and such other information concerning the Company and its subsidiaries and the New Notes as it deems necessary to enable it to make an informed investment decision concerning the
Notes Transactions. The Investor and each Account has been offered the opportunity to ask questions of the Company and its representatives and has received answers thereto as the Investor or such Account deems necessary to enable it to make an
informed investment decision concerning the Notes Transactions and the New Notes. Neither such inquiries nor any other due diligence investigations conducted by such Investor or its advisors, or its representatives shall modify, amend or affect such
Investor&#146;s right to rely on the Company&#146;s representations and warranties contained herein. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">l.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account understands that no federal, state, local or foreign agency has passed upon the
merits or risks of an investment in the New Notes or made any finding or determination concerning the fairness or advisability of such investment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">m.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account is an institutional &#147;accredited investor&#148; as defined in Rule 501 of
Regulation D under the Securities Act as well as a &#147;qualified institutional buyer&#148; as defined in Rule 144A under the Securities Act. The Investor, for itself and on behalf of each Account, agrees to furnish any additional information
reasonably requested by the Company or any of its affiliates to assure compliance with applicable U.S. federal and state securities laws in connection with the Notes Transactions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">n.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account is not directly, or indirectly through one or more intermediaries, controlling or
controlled by, or under direct or indirect common control with, the Company and is not, and has not been for the immediately preceding three months, an &#147;affiliate&#148; (within the meaning of Rule 144 under the Securities Act) of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">o.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account is acquiring the New Notes solely for the Investor&#146;s or such Account&#146;s
own beneficial account, or for an account with respect to which the Investor or such Account exercises sole investment discretion, for investment purposes, and not with a view to, or for resale in connection with, any distribution of the New Notes.
The Investor and each Account understands that the offer and sale of the New Notes have not been registered under the Securities Act or any state securities laws by reason of specific exemptions under the provisions thereof that depend in part upon
the investment intent of the Investor or each Account and the accuracy of the other representations made by the Investor and each Account in this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">p.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account understands that the Company is relying upon the representations and agreements
contained in this Agreement (and any supplemental information) for the purpose of determining whether the Investor&#146;s and such Account&#146;s participation in the Notes Transactions meets the requirements for the exemptions referenced in
<U>clause</U><U> </U><U>(o</U><U>)</U>&nbsp;above. In addition, the Investor and each Account acknowledges and agrees that any hedging transactions engaged in by the Investor or such Account after such Investor or Account was wall crossed and prior
to the Closing in connection with the issuance and sale of the New Notes have been and will be conducted in compliance with the Securities Act and the rules and regulations promulgated thereunder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">q.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account acknowledges that neither the New Notes nor the Underlying Shares have been
registered under the Securities Act. As a result, the New Notes, and if converted to Underlying Shares, the Underlying Shares, may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons, except pursuant
to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act as described in the Indenture. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">r.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account acknowledges that the terms of the Notes Transactions have been mutually
negotiated between the Investor (for itself and on behalf of each Account), and the Company. The Investor was given a meaningful opportunity to negotiate the terms of the Notes Transactions on behalf of itself and each Account.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">s.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account acknowledges the Company intends to pay an advisory fee to the Placement Agent.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">t.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor will, for itself and on behalf of each Account, upon request, execute and deliver any additional
documents, information or certifications reasonably requested by the Company, the Old Notes Trustee or the New Notes Trustee to complete the Notes Transactions. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">u.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account understands that, unless the Investor notifies the Company in writing to the
contrary prior to the Closing, each of the Investor&#146;s representations and warranties contained in this Agreement will be deemed to have been reaffirmed and confirmed as of the Closing, taking into account all information received by the
Investor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">v.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The participation in the Notes Transactions by any Exchanging Holder was not conditioned by the Company on such
Exchanging Holders&#146; exchange of a minimum principal amount of Exchanged Old Notes. No Subscriber&#146;s participation in the Notes Transactions was conditioned upon a minimum aggregate principal amount of New Notes issued for cash in the
Subscription. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">w.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor acknowledges that it and each Account had a sufficient amount of time to consider whether to
participate in the Notes Transactions and that neither the Company nor the Placement Agent has placed any pressure on the Investor or any Account to respond to the opportunity to participate in the Notes Transactions. The Investor acknowledges that
neither it nor any Account became aware of the Notes Transactions through any form of general solicitation or advertising within the meaning of Rule 502 under the Securities Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">x.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The operations of the Investor and each Account have been conducted in material compliance with the rules and
regulations administered or conducted by the U.S. Department of Treasury Office of Foreign Assets Control (&#147;<B>OFAC</B>&#148;), the rules and regulations of the Foreign Corrupt Practices Act (&#147;<B>FCPA</B>&#148;) and the Anti-Money
Laundering (&#147;<B>AML</B>&#148;) rules in the Bank Secrecy Act applicable to the Investor. The Investor has performed due diligence necessary to reasonably determine that its (or, where applicable, any Account&#146;s) beneficial owners are not
named on the lists of denied parties or blocked persons administered by OFAC, resident in or organized under the laws of a country that is the subject of comprehensive economic sanctions and embargoes administered or conducted by OFAC
(&#147;<B>Sanctions</B>&#148;), are not otherwise the subject of Sanctions and have not been found to be in violation or under suspicion of violating OFAC, FCPA or AML rules and regulations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">y.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account acknowledges and agrees that the Placement Agent has not acted as a financial
advisor or fiduciary to the Investor or such Account and that the Placement Agent and its respective directors, officers, employees, representatives and controlling persons have no responsibility for making, and have not made, any independent
investigation of the information contained herein or in the Company&#146;s Securities and Exchange Commission filings and make no representation or warranty to the Investor or such Account, express or implied, with respect to the Company or the
Notes Transactions or the accuracy, completeness or adequacy of the information provided to the Investor or the Account or any other publicly available information, nor will any of the foregoing persons be liable for any loss or damages of any kind
resulting from the use of the information contained therein or otherwise supplied to the Investor or such Account. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">z.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Investor and each Account acknowledges and agrees that no public market exists for the New Notes and that
there is no assurance that a public market will ever develop for the New Notes. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Conditions to Obligations of the Investor and the Company</U>. The obligations of the Investor to deliver,
or to cause the Accounts to deliver, the Exchanged Old Notes (if applicable) and the Cash Purchase Price (if applicable) and of the Company to deliver the New Notes are subject to the satisfaction at or prior to the Closing of the condition
precedent that the representations and warranties of the Company on the one hand, and of the Investor on the other contained in <U>Sections </U><U>5</U> and <U>6</U>, respectively, shall be true and correct as of the Closing in all material respects
with the same effect as though such representations and warranties had been made as of the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Covenant and Acknowledgment of the Company</U>. The Company hereby agrees to publicly disclose at or prior
to 9:00 a.m., New York City time (the &#147;<B>Release Time</B>&#148;), on the first business day after the date hereof, the Notes Transactions as contemplated by this Exchange/Subscription Agreement in a press release or through the filing of a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> The Company hereby acknowledges and agrees that as of the Release Time the Company will disclose all confidential information to the extent the Company believes such confidential
information constitutes material <FONT STYLE="white-space:nowrap">non-public</FONT> information, if any, with respect to the Notes Transactions or that was otherwise communicated by the Company to the Investor or any Account in connection with the
Notes Transactions. For the avoidance of doubt, the Company may be aware of material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company at the time of Closing that has not been communicated to the Investor or any
Account. The Company will, no later than the first business day following the Closing, file a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> publicly disclosing the closing of the Notes Transactions as contemplated by this
Exchange/Subscription Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Covenant of the Investor</U>. No later than one (1)&nbsp;business day after the date hereof, the Investor
agrees to deliver settlement instructions for each Purchaser to the Company substantially in the form of <U>Exhibit D</U> hereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Waiver, Amendment</U>. Neither this Agreement nor any provisions hereof shall be modified, changed,
discharged or terminated except by an instrument in writing, signed by the party against whom any waiver, change, discharge or termination is sought. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Assignability</U>. Neither this Agreement nor any right, remedy, obligation or liability arising hereunder
or by reason hereof shall be assignable by the Company or the Investor without the prior written consent of the other party. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Withholding</U>. The Company and its agents shall be entitled to deduct and withhold from any amounts
payable or deliverable pursuant to this Agreement such amounts as are required (as determined in good faith by the applicable withholding agent) to be deducted or withheld under applicable law. To the extent any amounts are withheld and remitted to
the appropriate taxing authority (including, for the avoidance of doubt, due to the failure or inability of an Investor (or Account(s) of such Investor, if applicable) to comply with the obligations set forth in Section&nbsp;13), such amounts shall
be treated for all purposes of this Agreement as having been paid or delivered to the Investor (or Account(s) of such Investor, if applicable) to whom such amounts otherwise would have been paid or delivered. The Investor (or Account(s) of such
Investor, if applicable) further acknowledges that any Investor (or Account(s) of such Investor, if applicable) may be subject to U.S. federal withholding or backup withholding (currently at rates of 30% and 24%, respectively) on certain payments or
deliveries made to such Investor (or Account(s) of such Investor, if applicable) unless such Investor (or Account(s) of such Investor, if applicable) properly establishes an exemption from, or a reduced rate of, such withholding or backup
withholding. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Required Tax Forms and Certifications</U>. The Investor (or Account(s) of such Investor, if applicable)
shall deliver to the Company, at least one (1)&nbsp;business day prior to the Closing, an accurately completed and duly executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> or IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> <FONT STYLE="white-space:nowrap">W-8IMY,</FONT> or other applicable IRS Form
<FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable (or any successor form), together with any required attachments. The Investor (or Account(s) of such Investor, if applicable) acknowledges that, if the Investor (or Account(s) of such
Investor, if applicable): (i) is a &#147;United States person&#148; (as defined in Section&nbsp;7701(a) of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;)), then the Company must be provided with a an accurately completed
and duly executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> certifying that such Investor or Account is exempt from backup withholding, or (ii)&nbsp;is not a &#147;United States person&#148; (as defined in Section&nbsp;7701(a) of the
Code) (a &#147;<B><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder</B>&#148;), then the Company must be provided with an accurately completed and duly executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> <FONT STYLE="white-space:nowrap">W-8IMY,</FONT> or other applicable <FONT STYLE="white-space:nowrap">W-8,</FONT> as
applicable (or any successor form), together with any required attachments, establishing an exemption from or a reduction in U.S. federal withholding. Without limiting the generality of the foregoing, the Investor (or Account(s) of such Investor, if
applicable) hereby represents that it is able to receive any amounts payable or deliverable hereunder (including any amounts attributable to accrued and unpaid interest) without any U.S. federal withholding tax and is entitled to provide U.S. tax
forms and required attachments indicating the same and, if such U.S. tax forms and attachments do not otherwise establish a 0% U.S. withholding tax rate on such amounts, hereby certifies that the Investor (or Account(s) of such Investor, if
applicable) fulfills the requirements of &#147;portfolio interest exemption&#148; as indicated in <U>Exhibit E,</U> and agrees to hold the Company and its agents harmless for the breach of such representation and certification. Any forms required to
be delivered to the Company pursuant to this <U>Section</U><U></U><U>&nbsp;13</U> shall be delivered in accordance with <U>Section</U><U></U><U>&nbsp;21</U>; provided that such communication shall be made via electronic mail. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Waiver of Jury Trial</U>. EACH OF THE COMPANY AND THE INVESTOR (FOR ITSELF AND, IF APPLICABLE, ON BEHALF OF
EACH ACCOUNT) IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING ARISING OUT OF THE TRANSACTIONS CONTEMPLATED BY THIS EXCHANGE/SUBSCRIPTION AGREEMENT. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law</U>. THIS AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO
CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Submission to Jurisdiction</U>. Each of the Company and the Investor (for itself and, if applicable, on
behalf of each Account)&nbsp;(a) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby shall be instituted exclusively in the courts of the State of New York located in
the City and County of New York or in the United States District Court for the Southern District of New York; (b)&nbsp;waives any objection that it may now or hereafter have to the venue of any such suit, action or proceeding; and
(c)&nbsp;irrevocably consents to the jurisdiction of the aforesaid courts in any such suit, action or proceeding. Each of the Company and the Investor (for itself and, if applicable, on behalf of each Account) agrees that a final judgment in any
such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Venue</U>. Each of the Company and the Investor (for itself and, if applicable, on behalf of each Account)
irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this
Agreement in any court referred to in <U>Section</U><U></U><U>&nbsp;16</U>. Each of the Company and the Investor (for itself and, if applicable, on behalf of each Account) irrevocably waives, to the fullest extent permitted by law, the defense of an
inconvenient forum to the maintenance of such action or proceeding in any such court. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Service of Process</U>. Each of the Company and the Investor (for itself and, if applicable, on behalf of
each Account) irrevocably consents to service of process in the manner provided for notices in <U>Section</U><U></U><U>&nbsp;21</U>. Nothing in this Exchange/Subscription Agreement will affect the right of any party to this Agreement to serve
process in any other manner permitted by law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Section and Other Headings</U>. The section and other headings contained in this Exchange/Subscription
Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Exchange/Subscription Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Counterparts</U>. This Agreement may be executed, either manually or by way of a digital signature provided
by DocuSign (or similar digital signature provider), by one or more of the parties hereto in any number of separate counterparts (including by facsimile or other electronic means, including telecopy, email or otherwise), and all of said counterparts
taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Exchange/Subscription Agreement (whether executed manually or by way of a digital signature as described herein this
Section&nbsp;20) by facsimile or other transmission (<I>e.g.</I>, &#147;pdf&#148; or &#147;tif&#148; format) shall be effective as delivery of a manually executed counterpart hereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notices</U>. All notices and other communications to the Company provided for herein shall be in writing and
shall be deemed to have been duly given if delivered personally or sent by registered or certified mail, return receipt requested, postage prepaid to the following addresses or pursuant to the following email addresses, or, in the case of the
Investor or any Account, the address provided in <U>Exhibit D</U> (or such other address as either party shall have specified by notice in writing to the other): </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">If to the Company:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3100 Hanover Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Palo Alto, California 94304</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Binding Effect</U>. The provisions of this Exchange/Subscription Agreement shall be binding upon and accrue
to the benefit of the parties hereto and their respective heirs, legal representatives, successors and permitted assigns. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notification of Changes</U>. The Investor (for itself and, if applicable, on behalf of each Account) hereby
covenants and agrees to notify the Company upon the occurrence of any event prior to the Closing that would cause any representation, warranty, or covenant of the Investor (and/or such Account) contained in this Agreement to be false or incorrect in
any material respect. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Reliance by Placement Agent</U>. The Placement Agent may rely on each representation and warranty of the
Company and the Investor made herein or pursuant to the terms hereof (including, without limitation, in any officer&#146;s certificate delivered pursuant to the terms hereof) with the same force and effect as if such representation or warranty were
made directly to the Placement Agent. The Placement Agent shall be a third party beneficiary to this Exchange/Subscription Agreement to the extent provided in this <U>Section</U><U></U><U>&nbsp;24</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Severability</U>. If any term or provision (in whole or in part) of this Exchange/Subscription Agreement is
invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Exchange/Subscription Agreement or invalidate or render unenforceable such term or provision
in any other jurisdiction. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Pages Follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Investor (for itself and, if applicable, on behalf of each Account) has executed
this Exchange/Subscription Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Legal Name of Executing Investor:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Legal Name:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Exchange/Subscription Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACCEPTED AND AGREED: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Guardant Health, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Exchange/Subscription Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A: FOR THE EXCHANGE </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name of</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exchanging</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Holder (i.e.,</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Beneficial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Owner)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Principal<BR>Amount of<BR>Exchanged<BR>Old Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Principal<BR>Amount of<BR>Exchanged<BR>New Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B: FOR THE SUBSCRIPTION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Participating Accounts, Allocation of Aggregate Principal Amount of Purchased New Notes and Cash Purchase Price: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Subscriber</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Purchased<BR>New<BR>Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Purchase<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C TO THE EXCHANGE/SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICE OF EXCHANGE/SUBSCRIPTION PROCEDURES </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attached are Exchange/Subscription Procedures for the settlement of the exchange and/or subscription for Guardant Health, Inc. (the
&#147;<B>Company</B>&#148;) Convertible Senior Notes due 2031 (the &#147;<B>New Notes</B>&#148;) pursuant to the Exchange/Subscription Agreement, dated as of February&nbsp;6, 2025, between you and the Company which is expected to occur on or about
February&nbsp;14, 2025. To ensure timely settlement, please follow the instructions for exchanging your 0% Convertible Senior Notes due 2027 (the &#147;<B>Old Notes</B>&#148;) (if applicable) and/or subscribing for New Notes (if applicable) as set
forth on the following page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>These instructions supersede any prior instructions you received. Your failure to comply with the attached
instructions may delay your receipt of the New Notes. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">If you have any questions, please contact [&#149;] at [&#149;]&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Thank you. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>OPTION A &#150; EXCHANGING OLD NOTES FOR NEW NOTES <U>ONLY</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><U>Delivery of Old Notes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">You must direct the eligible DTC participant through which you hold a beneficial interest in the Old Notes to post <B>on
February</B><B></B><B>&nbsp;14, 2025, no later than 9:00 a.m., New York City time,</B> <FONT STYLE="white-space:nowrap">one-sided</FONT> withdrawal instructions through DTC via DWAC, the aggregate principal amount of Exchanged Old Notes (CUSIP
40131MAB5 / ISIN: US40131MAB54) set forth in column 2 of <U>Exhibit A</U> (&#147;<B>Aggregate Principal Amount of Exchanged Old Notes</B>&#148;) of the Exchange/Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>It is important that this instruction be submitted and the DWAC posted on February&nbsp;14, 2025, no later than 9:00 a.m.,
New York City time. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B><U>To receive New Notes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">You must direct your eligible DTC participant through which you wish to hold a beneficial interest in the New Notes to post
and accept on February&nbsp;14, 2025, <B>no later than 9:00 a.m., New York City time</B>, a <FONT STYLE="white-space:nowrap">one-sided</FONT> deposit instruction through DTC via DWAC for the aggregate principal amount of Exchanged New Notes
(CUSIP/ISIN #: 40131M AC3/US40131MAD11) set forth in column 3 of <U>Exhibit A</U> (&#147;<B>Aggregate Principal Amount of Exchanged New Notes</B>&#148;) of the Exchange/Subscription Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman"><B>It is important that this instruction be submitted and the DWAC February&nbsp;14, 2025, no later than
9:00 a.m., New York City time. You must complete BOTH steps described above in order to complete the exchange of Old Notes for New Notes. </B></P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><B>OPTION B &#150; PURCHASING NEW NOTES <U>ONLY</U> (WITHOUT AN EXCHANGE OF OLD NOTES) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><B><U>To receive New Notes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">You must <B>BOTH</B>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Direct your eligible DTC participant through which you wish to hold a beneficial interest in the New Notes to
post and accept on February&nbsp;14, 2025, <B>no later than 9:00 a.m., New York City time</B>, a <FONT STYLE="white-space:nowrap">one-sided</FONT> deposit instruction through DTC via DWAC for the aggregate principal amount of New Notes (CUSIP/ISIN
#: 40131M AC3/US40131MAD11 set forth in column 2 of <U>Exhibit B</U> (&#147;<B>Purchased New Notes</B>&#148;) of the Exchange/Subscription Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>It is important that this instruction be submitted and the DWAC posted on February&nbsp;14, 2025, no later than 9:00 a.m., New York City
time. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><B>AND </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No later than</B> <B>3:00 p.m., New York City time, on February</B><B></B><B>&nbsp;14, 2025,</B> you must
pay the Cash Purchase Price set forth in column 3 of <U>Exhibit B</U> (&#147;<B>Cash Purchase Price</B>&#148;) of the Exchange/Subscription Agreement by wire transfer in immediately available funds to the following account of the Company:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">ABA Routing Number: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Beneficiary Account Name: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">SWIFT Code: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Beneficiary Account Number: [&#149;] </P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><B>OPTION C &#150; EXCHANGING OLD NOTES FOR NEW NOTES <U>AND</U> PURCHASING NEW NOTES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">For <B><U>that portion</U></B> of New Notes being acquired by means of an exchange for Old Notes, you must follow the steps outlined in Option
A above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">For <B><U>that portion</U></B> of New Notes you are acquiring in addition to those acquired pursuant to
Option A above, you must follow the steps outlined in Option B above. </P></div>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><B>SETTLEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">On February&nbsp;14, 2025, after the Company receives your Old Notes (if applicable) and/or your Cash Purchase Price (if
applicable) and your delivery instructions as set forth above, and subject to the satisfaction of the conditions to closing as set forth in your Exchange/Subscription Agreement, the Company will deliver your New Notes in accordance with the delivery
instructions set forth above. </P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D TO THE EXCHANGE/SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Purchaser Settlement Details </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>These
settlement instructions are to be delivered to the Company for each Purchaser no later than one (1)</U><U></U><U>&nbsp;business day after the date of the Exchange/Subscription Agreement. </U> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name of Purchaser: <U></U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchaser Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Country of Residence:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Taxpayer Identification Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>If Purchaser is an Exchanging Holder:</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>Exchanged Old Notes</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Phone Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Contact Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FFC Account #:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Account # at Bank/Broker:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>Exchanged New Notes (if different from Exchanged Old Notes)</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Phone Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Contact Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FFC Account #:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Account # at Bank/Broker:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If Purchaser is a Subscriber</U>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>DTC Participant Information for Delivery of Purchased New Notes</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Phone Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DTC Participant Contact Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FFC Account #:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Account # at Bank/Broker:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Tax Matters </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>U.S. Federal Backup Withholding
Tax </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under U.S. federal income tax law, an Investor (or Account(s) of such Investor, if applicable) generally must provide such Investor&#146;s (or
Account(s) of such Investor, if applicable) correct taxpayer identification number (&#147;<B>TIN</B>&#148;) on IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> (attached hereto) or otherwise establish a basis for exemption from backup
withholding. A TIN generally is an individual&#146;s social security number or an entity&#146;s employer identification number. If the correct TIN is not provided, the Investor (or Account(s) of such Investor, if applicable) may be subject to
penalties imposed by the IRS and certain payments made to them may be subject to U.S. backup withholding tax (currently set at 24% of the payment). If an Investor (or Account(s) of such Investor, if applicable) is required to provide a TIN but does
not have a TIN, the Investor (or Account(s) of such Investor, if applicable) should consult its tax advisor regarding how to obtain a TIN. Certain holders are not subject to these backup withholding and reporting requirements. A <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder may be required to comply with certain certification procedures to establish that the holder is not a &#147;United States person&#148; (as defined in Section&nbsp;7701(a) of the Code) in order to
avoid backup withholding. U.S. backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or credit against the applicable Investor&#146;s or Account&#146;s U.S. federal
income tax liability, provided that the required information is timely furnished to the IRS. In certain circumstances, information returns may be filed with the IRS. Copies of these information returns may also be made available under the provisions
of a specific treaty or agreement to the tax authorities of the country in which a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder resides. Investors (or Account(s) of such Investors, if applicable) are urged to consult their tax advisors
regarding how to complete the appropriate forms and to determine whether they are exempt from backup withholding or other withholding taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Portfolio
Interest Exemption (for Purchasers That Are <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders) </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under U.S. federal income tax law, an Investor
(or Account(s) of such Investor, if applicable) that is otherwise not eligible to provide an IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> may be subject to U.S. federal withholding tax on payments or deliveries attributable to accrued and
unpaid interest unless such Investor or Account establishes an exemption. To the extent required by Section&nbsp;13 of the Agreement, each Investor (or Account(s) of such Investor, if applicable) hereby claims such an exemption under the <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;portfolio interest exemption&#148; and represents and certifies as set forth in <U>Paragraph C</U> below (in addition to providing the applicable IRS Form
<FONT STYLE="white-space:nowrap">W-8).</FONT> However, if the Investor (or Account(s) of such Investor, if applicable) is an intermediary, a foreign partnership or other flow-through entity, then the adjustments in <U>Paragraphs A</U> and <U>B</U>
will be made to the statements below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following certification is made as applied to the Investor (or Account(s) of such Investor, if applicable):
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">record ownership under Clause 1 of <U>Paragraph C</U> below. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following certifications are made as applied to the partners/members that are beneficial owners of the Old
Notes claiming the portfolio interest exemption: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">beneficial ownership under Clause 1 of <U>Paragraph C</U> below, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the status in Clause 3 of <U>Paragraph C</U> below, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the status in Clause 4 of <U>Paragraph C</U> below. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following certification is made as applied to the Investor (or Account(s) of such Investor, if applicable)
as well as the partners/members that are beneficial owners of the Old Notes claiming the portfolio interest exemption: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is the sole record and beneficial owner of the Old Notes in respect of which it is providing this
certification. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is not a &#147;bank&#148; (within the meaning of Section&nbsp;881(c)(3)(A) of the Code).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is not a <FONT STYLE="white-space:nowrap">&#147;10-percent</FONT> shareholder&#148; of the Company (within
the meaning of Section&nbsp;881(c)(3)(B) or Section&nbsp;871(h)(3)(B) of the Code). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is not a &#147;controlled foreign corporation&#148; (as such term is described in Section&nbsp;881(c)(3)(C)
of the Code) related to the Company (within the meaning of Section&nbsp;864(d)(4) of the Code). </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d931211dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g931211g0207055812383.jpg" ALT="LOGO" STYLE="width:2.99167in;height:0.636111in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guardant Health Announces Debt Exchange Transactions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO ALTO, Calif. </B>February&nbsp;7, 2025 &#150; Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on
February&nbsp;6, 2025, it entered into privately negotiated exchange agreements (the &#147;Exchange Agreements&#148;) with certain holders of its outstanding 0% Convertible Senior Notes due 2027 (the &#147;2027 Notes&#148;), pursuant to which the
Company will issue $600&nbsp;million aggregate principal amount of 1.25% Convertible Senior Notes due 2031 (the &#147;New Notes&#148;) in exchange for the retirement of approximately $659.3&nbsp;million principal amount of 2027 Notes (the
&#147;Transactions&#148;). The initial conversion rate of the New Notes will be 16.0716 shares of Guardant Health&#146;s common stock (the &#147;common stock&#148;), per $1,000 principal amount of New Notes, which represents an initial conversion
price of approximately $62.22 per share of common stock, which reflects a conversion premium of approximately 35% to the last reported sale price of Guardant Health&#146;s common stock on February&nbsp;6, 2025. The maturity date of the New Notes is
February&nbsp;15, 2031. Following the closing of the Transactions, which is expected to occur on or about February&nbsp;14, 2025, subject to customary closing conditions, approximately $490.7&nbsp;million in aggregate principal amount of 2027 Notes
will remain outstanding with terms unchanged, in addition to $600&nbsp;million aggregate principal amount of the New Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the
Transactions, Guardant Health intends to repurchase approximately $45&nbsp;million of shares of its common stock from certain participants in the Transactions through a financial intermediary at the last reported sale price of the common stock on
February 6, 2025, and Guardant Health has been advised that the exchange agent for the Transactions intends to purchase approximately $35&nbsp;million of shares of Guardant Health&#146;s common stock from certain participants in the Transactions
through a financial intermediary at the last reported sale price of the common stock on February 6, 2025 (the &#147;Share Repurchases&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional
information regarding this announcement may be found in a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;that</FONT> Guardant Health intends to file today with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J. Wood Capital Advisors LLC acted as exchange agent to Guardant Health in connection with the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The New Notes and any shares of common stock issuable upon conversion of the New Notes have not been registered under the Securities Act of 1933, as amended,
or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release does not constitute an offer to sell, nor is it a solicitation of an
offer to buy, the 2027 Notes, the New Notes or Guardant Health&#146;s common stock, nor shall there be any sale of the New Notes or Guardant Health&#146;s common stock in any state or jurisdiction in which such an offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any state or any jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Guardant Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012,
Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes
across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the closing of the
Transactions and the effect of the Transactions and Share Repurchases on Guardant Health&#146;s common stock, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and
expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors.
These and additional risks and uncertainties that could affect Guardant Health&#146;s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release
include those discussed under the captions &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operation&#148; and elsewhere in its Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, and in its other reports filed with or furnished to the Securities and Exchange Commission thereafter. The forward-looking statements in this press release are
based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or
circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health&#146;s views as of any date subsequent to the date of this press release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Investor Contact: </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zarak Khurshid </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@guardanthealth.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Media Contact: </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Melissa Marasco </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">press@guardanthealth.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-647-3711</FONT></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Guardant Health, Inc. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gh-20250206.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/7/2025 12:38:05 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:gh="http://guardanthealth.com/20250206"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://guardanthealth.com/20250206"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20250206_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20250206_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gh-20250206_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/7/2025 12:38:05 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gh-20250206_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/7/2025 12:38:05 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gh-20250206.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g931211g0207055812383.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g931211g0207055812383.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ 1L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^HYYX;6!
MYYY4BB0;G=VP%'N:6::.W@DFF=4BC4L[L<!0.237DDTNJ?%+7I+>WDDM?#]J
M_+8^][GU8]AV'Z[T:/M+MNT5NS"O7]G9)7D]D;>J?%6T%R;30M/FU.?. P!5
M2?88R?R%51K?Q,O#YD&AV\"=E90I_P#'VS7=:+X?TSP_:BWTZU2(8PSXR[_[
MS=33M;UFVT+3_MET?W?F+& #R23C]!D_A5RKT8?!#YLFGA<16DHN;N^D3@CX
MQ\<Z.-^K^&UFA7[SPJ1@?[REA^E=+X<\?:+XC98(Y&MKP_\ +O/P6_W3T/\
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ME>;:+(MY\9M9NH2&A@MRCN#P" BG]0?RJ>73?B1J$?V2?4["UB88>:'AR/;
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L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45993496188624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001576280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GUARDANT HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-4139254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3100 Hanover Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-8887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !I-$=:[6M>1E $  "0$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V877.C-A2&_XJ&=GJ5A ]_A*2V9XB3;#R;S;JQMSO33B]DD&U-!&(E$2?_
MOD?@@-O%!]_$"#@OCXZ.7DD9[:1ZT5O&#'E+1:;'SM:8_-IU=;QE*=47,F<9
M/%E+E5(#3;5Q=:X83<J@5+B!YPW=E/+,F8S*>W,U&<G"")ZQN2*Z2%.JWF^8
MD+NQXSL?-Y[Y9FOL#7<RRNF&+9CYEL\5M-Q:)>$IRS27&5%L/78B__HFZ-N
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" !I-$=:EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !I-$=:!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( &DT1UJYAC 2[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &DT1UJ97)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M:31'6NUK7D90!   D!   !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &DT1UJ?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @ :31'6I>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @ :31'6APX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( &DT1UHD'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( &DT1UIED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d931211d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d931211d8k.htm">d931211d8k.htm</File>
    <File>gh-20250206.xsd</File>
    <File>gh-20250206_lab.xml</File>
    <File>gh-20250206_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d931211d8k.htm": {
   "nsprefix": "gh",
   "nsuri": "http://guardanthealth.com/20250206",
   "dts": {
    "inline": {
     "local": [
      "d931211d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gh-20250206.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gh-20250206_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gh-20250206_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-02-06_to_2025-02-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d931211d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-02-06_to_2025-02-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d931211d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://guardanthealth.com//20250206/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-022242-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-022242-xbrl.zip
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M@@,6$BIDX@9:FL?"V1Y4AQJQI;@@0'6J<=:]388.^M!LA ,'.IC"ZQ.'S^=
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MZ8R/16,8"/X=4Y[2$0-^XX,4K,T=BY9G&7VPJHL4+ >&BQJY! IKDW3FV7X
MWI!LSU4(+NK$C[PPF)_XSJ/<'>9%,941BEG@W^"P67_7Q<#YO7#Y+?C!2AP=
M.NLL=R+3*YH_D'\/CC4T@S](5\"S(0SU4'O?;5N8=;(:W?W=_6XEM_Y!3+OF
M=V<FIV83EQ[-P4[MJ+?3Z%G=?F>GMP8+GT##]Q^HX _UWQN)M[?()F LXD,(
M$+ _( )0CJ1(!?SYO?"%]03TR:S](C*#,??D_^CSMO:9SZ(1+[M*)_YT*A46
M-5]\1=#@,:VO_Q[^GUU>L=/IS/7G(GCQ%<B;3G;N-].%(+L&_X?([Q'1^D9"
M@Q5.X-AQ J&4^><S@'/K$0Z@6SOJ NYDG[CG@T2QJS 0(EP17;] O+0>4T[@
MSZ_!M7_K/8(EO=K1!7=]=NR&?I$1]56QK"&$W,/7X (PGJ0"]=,AQIW:T0GP
M"M[P)%]5N:T@]\*' =S_D[,'P=N4EMW:4;\''-RD_&S&$IF)8JP]"V!)Y(R[
M3-P).PKE#8;@8!>$VF9;P 2&7%B27WP^2[ 2+SX84**F' -J>^2"8\9_IY2,
M:U0.^]D'CW4Q\;W'@__]VM%N?[^QO[^_MPJXOK3PI0FN__RPW['V#A0+A2MF
MR ?F$2/J#(32C1S!(/+CP)6R!+YF>S93,5FEFF!/)\+^3KE]/@.C"P8#P?[0
MOV-#X?JW3.K$_P<PTJN+;E01(T%D(PG<'3.I8+%#X3G"P0*'DM/(#;DG_$BY
M<Z9 !=1H3B.8%_PA\,M >3UT)E\803\!X]X\?C;R72 2WT.'(1']JD&E+.T^
M-#^VJ?R7E6Y;&+0SF;!RQJV0D5LK#JTMRE;U?CI8CIY1%I<8SU\#&<+Z8701
M>09/JD?[^*'ONT,.:Q>"I&4M71_YW]_K]0[*ANY^48&>5T8.6'[IV:/=6FDP
MPRM@3I99;):I\%U&($Z]SHX1Y4)-#4MI6]8>._EPR3K==A,:KL;MK_+]&/F^
M MMM _>]\1<P?&#]W"<3;JO]=Q;NE%'0M>946;)7>@BKQQM6)W82J1+DJLFQ
M"JSLK=-K-W6/VQD ]*HM3Z8M%X% 3X"[,6D/#3KVX.MH] !TN[;66']GK5DI
MPL#1AIUA::P:JWS(&IKF-#I;P^W-ZIKN\U7;7D+;SI2*1/ L.M=YU;D'Z5Q7
M-'I;]F9USO2YMLYM/$3, %0=BXD HKE9Y;XUM!!Q@ ;3K8['7C<L_+TW+)3+
MF6ND1RIF4)+^1U5XGJ*F<HUGHO160GO";)<KM9'BUH-Y]E<K@5T''!7PQ8M?
M5_,I/-I2FZD]_F.6Y]SLOR/Q%<8?O?AB^1X#W0>*4M>2]W!_E3U6E0D$[1WG
M5F=(%N+A:7ZK6SM"O <LN0I]^WN=_=ANHH!9;,8#=L/=2+ 9'D^;+-PR]3S;
M?JKX8+1?*]\CF-"K'7W\]%>;7+S(,8Q[T.;=(OI&'2S5.*T=,*0 G,ZY<OB?
M[*/K T '@.4"Q&)?>/!]4<7Z.='@F><@0A9L.&<V%0^@Q^^@Q()V!Q4R]E(Q
M@+B LG'0,1L'_FTX0: ]PRP^5\P1(^GIW;\Z-]K>8>7#!ND9@R[;PC7>.Z#\
M:-Q8TK[A&>X;QAU :Z+USK"1I*+6.^"PNM.8.D3NI?XS9#:?MN9:.SI=S//_
M_+!O]2&L6UXKCU_^2.^>Z%>?+MS<71)N/BV7SD9+Y!,+E0N%798J4Q,09=)1
M$&7/IZ H4H): <-,_0OO )!4VM)G=)%!-)8[Q\%O)0R-:N$!?? D$#=2P7N@
M(-RS,=_*;1NWYF)CO W X8&C=.7+61J1=;=X$I%EQ;III"%A?D6@MG_O&NP_
M[5RO+L2:<NR;-XLE4DQ+ HE?94#+4,"2 VAQ;_E<U?3AC#>'DP3?0(#J!X,?
M^O2_@W@VL[ML$&J[@@?H\"84[KU94>_>[(GM-\6\W+NOE^]/+QLG7S]_/KZX
M.AW$?_R5\W*6M69B;OD6Y[-03'&30]LZ ,FVUMU^_>P)LF4P7(]^BMO]L5#O
M,\[B.AA[CZY9TIZAXW$@*%7&[I-^VJVPT#0^F%;H#W.D][/87SVV\)1<G7TT
M-]:P3W1E39V=>7:3;:'1PV7JM ].$A_8Z5@'VXQ4A, 'S'P6R!N8NHOV=^R'
MN _"2>(DQF,.J%R/J35-GB>]DSVW8?$Y@)L),%X$M"D+3SGY44@6'$UY^R=V
MXGLD):A85\*38/W/_1 F[@#DA]GMY0:E+^AY/%8]9_QU0(4OF D#*:X+6$Q!
M;S_NMMN:<<!?%YT1'P/M8_1RZ78Q/D5'0["GV=E926#7RA&(RY6C#^%=PDKT
M>MI]AC+04@7CT/:3.SG52_#C[DZ_V<W3N8BZE!4Y J[1U7)R@0D-3?8AV2V"
M36W75[3C1/O%["MUPT+ :^)NIKTZ\-6W 1PRO<F<#V$)"Y)H];0HYF7.#(.'
M1]/E4M'P#T3TT*L=*= ,Z"2A"&"6(PTA!;;T^NWF7IXM<M4*9GA$<@ \1XG,
MBB")*NC"5+'(T\OD-)<<'=1G=3>MVF>X=<+S-'0Q-)56)BO6>FN10BX& C0
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M$WR!\ACM52*3G;'8F4E5,(+P;XX/AG=+'#\X $_O9()N1&Q1,FWY8L84V6C
MI:[;>57H38=AI+%+ !J%:ZG*9] >=ITO9V*Y.Q=/@6$45*S&GN/\/4X*R[@X
M\B@*2)%3:V2T:3BGY]HP0*PUTM)"C4N+H6>K#0_%)6!=HQA+>G53SZ+:1QU[
M-F/DF5\WHXO,IH$T'MY) NGE9=]J_E2/G!01$QH1R3O"=KE!\L^P>@3>%ZY7
M9DF;[!,8CQOT)3 37,CT?0(AP!D_ ?'95!ME<^OYQ%H]+8ZBO&.)7#AS,E.+
M5"[K-F-[9)QPR5Q6.&6=6M'5_DKWC#X7<+O2,8D"F^XF"J8K#N9#5E@HQK(%
M)CU4L6I4@ELXPVB&[UC[L2O!*"P%(PO*13JI0UM7J%SD5RIV?K27CKVK:ZJF
M+!ZG1RCA&._N-,DZL\D25C>WM[*WQ;>W.LGNRL5[EG4)8ZJW@6;+H/GFZ4Z5
M;'I8$I:?F_(@;2)>1NDPSIE0/M?WTB*"02=3[HA82,%W@%CX@2J#?//%@@U.
MS[^,QZ )LT3RZ2X:^+M,&O)J)%U=U3Z]F\BA#)G5;EIZB>'I"<5 (;O4U\-C
M)>*^-]L8VYY>.ZFE(OF9(@:.04A3+$KL$!A190=REKW99OE$,..1NQD;K_0+
M!*#QW&@8<T1THH>FVV1Y9LWH*C 0($+CH,.@F79L)?,;/5#U0XYI;IH".OF4
MB_T^<''1U/5L<S2]A)YO9FT=7Z@DJQPGVG"]1@CA?1/9>!CL*,PR<MHQ;)M"
M"/GI3.MA-"]N43!P?UEZ1?>O)N@L$61@I8>\*R7A2^YSC1XI#L .XHM<<U>X
M)LE;$J.8_GIA9H$>_M:/7 <)BCR7WXXBS&#B7@MR.ADK!%\9^3574*91D$IM
M'G2AP4V6./R0)? UW?2Z"7NM3=C=9KOS-]Z$_<W+G*Z_ F4CU3C],\($3 8H
MO/@.[&O"J,F/6>)6#O1S &ZUDN.2,-P1GQQZVH!E7LOM'*,=67_G(6%^# E2
M3$C;!8JEJ248DI"\*RF_0N_FP"&>N]GJ5X%#GDWP\\P&Z4($D07_%$-0WL6<
M2(PWEF,14.J\&*!-F-6=G.H]'%:WWK;VZOW=]GUXLQY;B"4:<9H@(-ZD$A-0
M+ 3B?F2KN=O?W<@&&:DJ=H  5&HX$)#I#07)?I!,@KP$4C(Z<._S3J_V>($]
M[H,):/Z-#?*'9(,Q77$\-?NPG!@3&Q%ZK"V^E^W=<K8+PR^6X,X3WZRR&0E?
MXVJ5-V_TY2KTC],R_ZYS'4KYZA7]?;_[;->A/.:NDQ5Z9H3@<!BTCL[]M=4L
M?TY^S=/RE72OI/)]&O26?EK#K.P"X2WQ,;ZC%QZT*I^ %T')]=[6.B_Y^SP+
M3YJWF];3+ WM43OD3/_HLM/O6AW+<L2=!:9W$D)OU3F&PQ:ONF;CG[P6F,AX
MWK7H]\U:7.1R,; H"T\LQ@<S\ML:]^+? OQ7+IJ%]^P_V9J=T,]!7,#T8 '
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M!W8-1X&-EWI$(TF</1*\13R?Z\MXHK:39RPNX<JAE!&0;7@CO#R[C!/8$U\
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M@T)1&GEJQ=@+$ P; X>JI7&/3@SGU]0+.=Y OYL615E,BH(YW9W403PC*=_
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M,E H;>:OW&=FXZP73-"(_LJCD4G0H*28U.K\45&)5IDD^MA6'[G.@([[BSQ
M0R-2J32&-US;KP*K$C.DI.NS<YZR1B"7Y0RDX0UY2S"VANHVV"N<P^4F%W4[
M!@9JK6*SS'LJ/L2@3IJFU?,RQ9IV:D9ZV)S--5D[*B4GP'08CA&BQ*.TL39[
MX@E6%YV7J-EE,4/$1'= .8'OY-@5?(M-+8@8WPX5]FXGC[C872=3T4W8XK!X
M"RODF![8U 2VY)E7,54^F7415)W/9@;D'>5547MVR9E5%XI%[6S'!63>*0@X
MKKYJ3]PG5D%S7NNTT@)759*"=77#OBE4\QRFH@.' 0/T(<M>1\X9X034;J?
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MFK10>R7/KJZIN;$)8JX[NM!X57E"F14VM];ZQ;=%=-+MD-]3TJE-L5J@'8U
MQ/*G\+X)GOH*MX:;VWJ![U!+C>EYAP72X5^8JG4&7%.3-*>[;GD"I:RN^L?;
M*HG*\\=Y0M*VFMB+Q'3G92FO@>-H+R 1NJ2/IPL\/9\6ONV-V+H.R2>0, S
M6&QM_$K$_'+[UZ);>PWM;RSR\@C[Z$9WW 6EC;<JD JD".92A!:Y[=I4@<[]
M!D'60V@$ 3_#-T%Z24ZS.G "!&( @0#$AMM . <T=NTFLF->??TSA?TW-]JX
M_U/02+964R,YU8?\N?>=_'SLXMXOE)5:7>6N<J';877&Q"X+#I$^RD+TGF<S
MO#3UI7\,[)<GC'&ITZI8,_!SE$-<7NN+H].S!1V97Y^_U8Y,>.)M[GNS=WC<
MU_?R]=W.C#L6'/+YH1JS./3L^P[WC_JWN?[HCS_[SK+96''T,KT/0, +C&:&
M0F72#M+30('<X(J1;R:8CAY?<+V,ZLMZ8]5/+\N\T24=?/<CPJHR0%<LH.<T
M*QH[H%&N<3\<CJ<5$7XXD4X#JA;QF@MZW>O7&YL];\TZ,D&\(J[RJ;R248Z<
MXI-ZNOGVS:L^;2HZA% Y+X3R\#(GA,=Y_H6$2C')4T(I,FF%"I:R@9.ZG0=B
M):Y4OS%ACT8<-.JZ@]H"6S95)8JTAUX0*"FA@'H?] 5@DT\?**;GV;V=N]CC
M4M]=+J4L5UTL]#:6(M66)IWZ*R">;BF4@*P?3"KUK;++W>=+VJZC[.J2UR:K
M85U\5=ZD,)@$IGF5*GASVFN;7-W^K>TT=^EK.LAM4EIL^:/3RDIWDG4-\08G
M@_&O.:9VT8#/&,Y6CXVP^KFB[3PB0Y!PM&&^:\:WA@,T6EK45IOAL%U?B6(I
MO@^NZ7;&1K^I>XT$OCVR'<,H 8B2EP*UBWHD80=R[_?C4H&+(0MX_6#@T>WE
MB;/M$Q4,Y;Y^*PK=PZTZN/N;'N?A. C#&N1-N)>E' 9\QW$8Q.856%*V/0?4
M/IE4+1VN0CF@<K1LM(Q<5%FSF^O22R9D=VIO#*KA#.=0DVO%:5VN<KHN!JHR
M-+5O%5U!Y' JN3/T'"J>,)MPIM+-U!_M=*&%&8^<'3=@7.G$M\5^LX=ZN8D?
MWSE)_>8L++:?M@$;-.ZO D_($(9-XHBR8X.P+5E:LL6VO9H6&T<$D3_^"VM
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M#PZ2!=7FWUEK0)45'C,*O6"BINY.S1%O"YSC:?Q\!">+1<CDLW6JF<1NE7F
M.F.5"@&_T4O06A](3YE6$#Z0[[P$1*DWO13[A \PE(B&TRLAZS 9T5LNG62*
MJ,"BG$]5;]8<-KR60!FTB_=2UK0JCV(/L>N2&X0@13L?#&Y"4(43.[T,IE;
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MUWOLEWT+$$O^ 5!+ 0(4 Q0    ( &DT1UJ<,6J7[AD  &./   .
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M;&%B+GAM;%!+ 0(4 Q0    ( &DT1UK=\RW<N00  'XJ   3
M  "  8!\  !G:"TR,#(U,#(P-E]P<F4N>&UL4$L%!@     &  8 >0$  &J!
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d931211d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gh-20250206.xsd" xlink:type="simple"/>
    <context id="duration_2025-02-06_to_2025-02-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001576280</identifier>
        </entity>
        <period>
            <startDate>2025-02-06</startDate>
            <endDate>2025-02-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-286">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-02-06_to_2025-02-06"
      id="Hidden_dei_EntityCentralIndexKey">0001576280</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-297">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-298">2025-02-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-299">GUARDANT HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-300">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-301">001-38683</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-302">45-4139254</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-303">3100 Hanover Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-304">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-305">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-306">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-307">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-308">698-8887</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-309">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-310">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-311">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-312">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-313">Common Stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-314">GH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-315">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-02-06_to_2025-02-06" id="ixv-316">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
